Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$133,142,734
+$35,626,216 QoQ
Shares Held
3,762,157
+6.9% QoQ
Ownership
0.521%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. ROIV ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ROIV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,142,734 | 3,762,157 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $97,516,518 | 3,520,452 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $71,304,635 | 3,285,928 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $49,672,711 | 3,283,061 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $36,438,318 | 3,233,214 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $33,310,103 | 3,301,299 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $40,790,806 | 3,448,082 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $32,259,687 | 2,795,467 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $25,295,499 | 2,393,141 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $17,552,629 | 1,665,335 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $16,615,278 | 1,479,544 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16,927,156 | 1,449,243 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,912,674 | 884,194 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,163,289 | 428,630 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,177,742 | 397,715 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $952,845 | 295,915 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,083,066 | 266,110 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $817,634 | 165,513 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,696,907 | 168,344 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||